{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:15:38Z","timestamp":1777958138673,"version":"3.51.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01705-w","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:51:49Z","timestamp":1777888309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Moroccan national guidelines for the management of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"21","author":[{"given":"Mirieme","family":"Ghazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anass","family":"Kherrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyass","family":"Chergaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Toufik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"El Jadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Amine","family":"Benhima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radouane","family":"Niamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellah","family":"El Maghraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"6","key":"1705_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, WHO Study Group (1994) Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4(6):368\u2013381","journal-title":"Osteoporos Int"},{"key":"1705_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Huang X, Wu J et al (2022) The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019. Front Endocrinol (Lausanne) 13:882241. https:\/\/doi.org\/10.3389\/fendo.2022.882241","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1705_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-024-01421-3","volume":"19","author":"A Kherrab","year":"2024","unstructured":"Kherrab A, Toufik H, Ghazi M, Benhima MA, Chbihi-Kaddouri A, Chergaoui I, Niamane R, El Maghraoui A (2024) Prevalence of postmenopausal osteoporosis in Morocco: a systematic review and meta-analysis. Arch Osteoporos 19(1):61. https:\/\/doi.org\/10.1007\/s11657-024-01421-3","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1705_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00198-012-2061-3","volume":"24","author":"A El Maghraoui","year":"2013","unstructured":"El Maghraoui A, Ngbanda AR, Bensaoud N, Bensaoud M, Rezqi A, Tazi MA (2013) Age-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, Morocco. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 24(4):1267\u20131273. https:\/\/doi.org\/10.1007\/s00198-012-2061-3","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1705_CR5","unstructured":"(2007) Recommandations de la Societe Marocaine de Rhumatologie pour la prise en charge de l\u2019osteoporose post-menopausique. Rev Mar rhum. 2007:77\u201392"},{"key":"1705_CR6","doi-asserted-by":"publisher","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 105(3):dgaa048. https:\/\/doi.org\/10.1210\/clinem\/dgaa048","DOI":"10.1210\/clinem\/dgaa048"},{"issue":"1","key":"1705_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-01035-z","volume":"16","author":"Y El Miedany","year":"2021","unstructured":"El Miedany Y, Paruk F, Kalla A, Adebajo A, El Gaafary M, El Maghraoui A, Ngandeu M, Dey D, Gadallah N, Elwy M, Moosajee F, Abu-Zaid MH, Galal S, Miladi S, Hassan W, Fadlelmola A, Saber S (2021) Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: an initiative by the African Society of Bone Health and Metabolic Bone Diseases. Arch Osteoporos 16(1):176. https:\/\/doi.org\/10.1007\/s11657-021-01035-z","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1705_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01588-3","volume":"20","author":"CL Gregson","year":"2025","unstructured":"Gregson CL, Armstrong DJ, Avgerinou CA et al (2025) The 2024 UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 20(1):119. https:\/\/doi.org\/10.1007\/s11657-025-01588-3","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3\u201344","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"1705_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2020 update. Endocr Pract 26(Suppl 1):1\u201346","journal-title":"Endocr Pract"},{"key":"1705_CR11","doi-asserted-by":"crossref","unstructured":"El Miedany Y, Abu-Zaid MH, El Gaafary M, Hasab El Naby M, Fathi N, Saber HG et al (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of Bone Health and Metabolic Bone Diseases. Egypt Rheumatol Rehabil 48(1):5","DOI":"10.1186\/s43166-020-00056-9"},{"issue":"3","key":"1705_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1210\/clinem\/dgaa048","volume":"105","author":"D Shoback","year":"2020","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 105(3):587\u2013594. https:\/\/doi.org\/10.1210\/clinem\/dgaa048","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR13","doi-asserted-by":"crossref","unstructured":"(2001) NIH consensus development panel on osteoporosis prevention d and therapy. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285(6):785\u201395","DOI":"10.1001\/jama.285.6.785"},{"key":"1705_CR14","doi-asserted-by":"crossref","unstructured":"Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. The Lancet 359(9321):1929\u201336","DOI":"10.1016\/S0140-6736(02)08761-5"},{"issue":"4","key":"1705_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jocd.2006.07.001","volume":"9","author":"A El Maghraoui","year":"2006","unstructured":"El Maghraoui A, Guerboub AA, Achemlal L, Mounach A, Nouijai A, Ghazi M et al (Oct2006) Bone mineral density of the spine and femur in healthy Moroccan women. J Clin Densitom 9(4):454\u2013460","journal-title":"J Clin Densitom"},{"key":"1705_CR16","doi-asserted-by":"crossref","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u201375","DOI":"10.1016\/j.bone.2007.11.001"},{"issue":"4","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jocd.2019.07.004","volume":"22","author":"PA Anderson","year":"2019","unstructured":"Anderson PA, Morgan SL, Krueger D, Zapalowski C, Tanner B, Jeray KJ et al (2019) Use of bone health evaluation in orthopedic surgery: 2019 ISCD official positions. J Clin Densitom 22(4):472\u2013589. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.004","journal-title":"J Clin Densitom"},{"issue":"7","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1359\/JBMR.050304","volume":"20","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185\u20131194","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","volume":"18","author":"KL Stone","year":"2003","unstructured":"Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18(11):1947\u20131954","journal-title":"J Bone Miner Res"},{"key":"1705_CR20","doi-asserted-by":"crossref","unstructured":"Cummings SR, Browner W, Cummings SR, Black DM, Nevitt MC, Browner W et al (1993) Bone density at various sites for prediction of hip fractures. The Lancet 341(8837):72\u20135","DOI":"10.1016\/0140-6736(93)92555-8"},{"issue":"6","key":"1705_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jbmr.5650070607","volume":"7","author":"DM Black","year":"1992","unstructured":"Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W (1992) Axial and appendicular bone density predict fractures in older women. J Bone Miner Res 7(6):633\u2013638","journal-title":"J Bone Miner Res"},{"key":"1705_CR22","doi-asserted-by":"crossref","unstructured":"Paggiosi MA, Glueer CC, Roux C, Reid DM, Felsenberg D, Barkmann R et al (2011) International varia-tion in proximal femur bone mineral density. Osteoporos Int 22(2):721\u20139","DOI":"10.1007\/s00198-010-1336-9"},{"issue":"1","key":"1705_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101435","volume":"27","author":"C Shuhart","year":"2024","unstructured":"Shuhart C, Cheung A, Gill R, Gani L, Goel H, Szalat A (2024) Executive summary of the 2023 adult position development conference of the International Society for Clinical Densitometry: DXA reporting, follow-up BMD testing and trabecular bone score application and reporting. J Clin Densitom 27(1):101435. https:\/\/doi.org\/10.1016\/j.jocd.2023.101435","journal-title":"J Clin Densitom"},{"key":"1705_CR24","doi-asserted-by":"crossref","unstructured":"Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S (2012) What\u2019s in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int 23(8):2093\u20137","DOI":"10.1007\/s00198-012-1991-0"},{"issue":"5","key":"1705_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"ES Siris","year":"2014","unstructured":"Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25(5):1439\u20131443","journal-title":"Osteoporos Int"},{"issue":"5","key":"1705_CR26","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1148\/rg.315105712","volume":"31","author":"G Guglielmi","year":"2011","unstructured":"Guglielmi G, Muscarella S, Bazzocchi A (2011) Integrated imaging approach to osteoporosis: state-of the-art review and update. Radiographics 31(5):1343\u20131364","journal-title":"Radiographics"},{"issue":"2 Suppl","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194(2 Suppl):S3-11. https:\/\/doi.org\/10.1016\/j.ajog.2005.08.047","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1705_CR28","first-page":"1243","volume":"27","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA et al (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res Off J Am Soc Bone Miner Res. Juin 27(6):1243\u20131251","journal-title":"Juin"},{"issue":"6","key":"1705_CR29","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/jbmr.35","volume":"25","author":"LM Giangregorio","year":"2010","unstructured":"Giangregorio LM, Leslie WD (2010) Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25(6):1400\u20131405","journal-title":"J Bone Miner Res"},{"key":"1705_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-020-00688-1","volume":"107","author":"SJ Mortensen","year":"2020","unstructured":"Mortensen SJ, Mohamadi A, Wright CL, Chan JJ, Weaver MJ, von Keudell A, Nazarian A (2020) Medications as a risk factor for fragility hip fractures: a systematic review and meta-analysis. Calcif Tissue Int 107:1\u20139","journal-title":"Calcif Tissue Int"},{"key":"1705_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","volume":"81","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81:153\u2013161","journal-title":"Calcif Tissue Int"},{"key":"1705_CR32","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"ME Arbouw","year":"2011","unstructured":"Arbouw ME, Movig KL, van Staa TP, Egberts AC, Souverein PC, de Vries F (2011) Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int 22:2197\u20132204","journal-title":"Osteoporos Int"},{"issue":"8","key":"1705_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/1756-185X.13897","volume":"23","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Pok LSL, Ng CM, Yahya F, Sockalingam S, Tee YC et al (2020) Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. Int J Rheum Dis ao\u00fbt 23(8):1088\u20131093","journal-title":"Int J Rheum Dis ao\u00fbt"},{"key":"1705_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25826","volume":"3","author":"ZW Myint","year":"2020","unstructured":"Myint ZW, Momo HD, Otto DE, Yan D, Wang P, Kolesar JM (2020) Evaluation of fall and fracture risk among men with prostate cancer treated with androgen receptor inhibitors: a systematic review and meta-analysis. JAMA Netw Open 3:e2025826","journal-title":"JAMA Netw Open"},{"key":"1705_CR35","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00198-015-3123-0","volume":"26","author":"A Palermo","year":"2015","unstructured":"Palermo A, D\u2019Onofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int 26:2073\u20132089","journal-title":"Osteoporos Int"},{"key":"1705_CR36","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1210\/jc.2017-01642","volume":"102","author":"N Singh-Ospina","year":"2017","unstructured":"Singh-Ospina N, Maraka S, Rodriguez-Gutierrez R, Davidge- Pitts C, Nippoldt TB, Prokop LJ, Murad MH (2017) Effect of sex steroids on the bone health of transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102:3904\u20133913","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1705_CR37","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10067-010-1535-y","volume":"29","author":"F Allali","year":"2010","unstructured":"Allali F, Rostom S, Bennani L, Abouqal R, Hajjaj-Hassouni N (2010) Educational level and osteoporosis risk in postmenopausal Moroccan women: a classification tree analysis. Clin Rheumatol 29(11):1269\u20131275","journal-title":"Clin Rheumatol"},{"key":"1705_CR38","doi-asserted-by":"crossref","unstructured":"Allali F, Maaroufi H, Aichaoui SE, Khazani H, Saoud B, Benyahya B et al (2007) Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturi-tas 57(4):392\u20138","DOI":"10.1016\/j.maturitas.2007.04.006"},{"key":"1705_CR39","doi-asserted-by":"crossref","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthe-sis. J Bone Miner Res 15(4):721\u2013739","DOI":"10.1359\/jbmr.2000.15.4.721"},{"issue":"5","key":"1705_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","volume":"14","author":"DM Black","year":"1999","unstructured":"Black DM, Arden NK, Palermo L, Pearson J, Cummings SR, Group for the S of OFR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 14(5):821\u20138","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1705_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00198-013-2460-0","volume":"25","author":"H Johansson","year":"2014","unstructured":"Johansson H, Oden A, McCloskey EV, Kanis JA (2014) Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporos Int 25(1):235\u201341","journal-title":"Osteoporos Int"},{"key":"1705_CR42","doi-asserted-by":"crossref","unstructured":"Melton LJ III, Atkinson EJ, Cooper C, O\u2019Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214\u201321","DOI":"10.1007\/s001980050218"},{"issue":"2","key":"1705_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00198-005-2017-y","volume":"17","author":"K Siminoski","year":"2006","unstructured":"Siminoski K, Warshawski RS, Jen H, Lee K (2006) The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int 17(2):290\u20136","journal-title":"Osteoporos Int"},{"issue":"2","key":"1705_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.020","volume":"62","author":"A El Maghraoui","year":"2009","unstructured":"El Maghraoui A, Morjane F, Nouijai A, Achemlal L, Bezza A, Ghozlani I (2009) Vertebral fracture assessment in Moroccan women: prevalence and risk factors. Maturitas 62(2):171\u2013175. https:\/\/doi.org\/10.1016\/j.maturitas.2008.11.020","journal-title":"Maturitas"},{"key":"1705_CR45","unstructured":"(2005) Prevention des chutes accidentelles chez la personne agee. Haute Autorite de Sante. https:\/\/www.has-sante.fr\/jcms\/c_272503\/fr\/prevention-des-chutes-accidentelles-chez-lapersonne-agee"},{"issue":"3","key":"1705_CR46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Od\u00e9n A, Leslie WD, McCloskey EV (2017) FRAX update. J Clin Densitom 20(3):360\u2013367. https:\/\/doi.org\/10.1016\/j.jocd.2017.06.022","journal-title":"J Clin Densitom"},{"issue":"4","key":"1705_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11914-010-0032-1","volume":"8","author":"SL Silverman","year":"2010","unstructured":"Silverman SL, Calderon AD (2010) The utility and limitations of FRAX: a US perspective. Curr Osteoporos Rep 8(4):192\u2013197","journal-title":"Curr Osteoporos Rep"},{"key":"1705_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2014.01.014","volume":"62","author":"OI Kreidieh","year":"2014","unstructured":"Kreidieh OI, El-Hajj Fuleihan G (2014) Impact of changes in mortality on FRAX-derived fracture proba-bilities. Bone 62:43\u201350","journal-title":"Bone"},{"key":"1705_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-365","volume":"15","author":"A El Maghraoui","year":"2014","unstructured":"El Maghraoui A, Sadni S, Jbili N, Rezqi A, Mounach A, Ghozlani I (2014) The dis-criminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study. BMC Musculoskelet Disord 15:365","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"1705_CR50","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N et al (2014) Trabecular bone score: a non-invasive analytical method based upon the DXA image. J Bone Miner Res 29(3):518\u2013530","journal-title":"J Bone Miner Res"},{"key":"1705_CR51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","volume":"78","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Gluer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C et al (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216\u2013224","journal-title":"Bone"},{"issue":"5","key":"1705_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31(5):940\u2013948","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1705_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jbspin.2015.02.005","volume":"82","author":"V Bousson","year":"2015","unstructured":"Bousson V, Bergot C, Sutter B, Thomas T, Bendavid S, Benhamou CL et al (2015) Trabecular bone score: where are we now? Joint Bone Spine 82(5):320\u20135","journal-title":"Joint Bone Spine"},{"key":"1705_CR54","doi-asserted-by":"crossref","unstructured":"Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A,M. Ghazi et al (2014) 17 Revue Marocaine de Rhumatologie McCloskey EV, et al. Lumbar spine texture enhances 10- year fracture probability assessment. Osteoporos Int 25(9):2271\u20137","DOI":"10.1007\/s00198-014-2761-y"},{"issue":"67","key":"1705_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bone.2014.06.034","volume":"1","author":"WD Leslie","year":"2014","unstructured":"Leslie WD, Aubry-Rozier B, Lix LM, Morin SN, Majumdar SR, Hans D (2014) Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program. Bone 1(67):10\u201314","journal-title":"Bone"},{"issue":"1","key":"1705_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-177","volume":"13","author":"GA Kelley","year":"2012","unstructured":"Kelley GA, Kelley KS, Kohrt WM (2012) Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 13(1):177","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"1705_CR57","volume":"2012","author":"LD Gillespie","year":"2012","unstructured":"Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson L et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012(9):CD007146","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1705_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-015-0041-2","volume":"12","author":"A El Maghraoui","year":"2015","unstructured":"El Maghraoui A, Sadni S, El Maataoui A, Majjad A, Rezqi A, Ouzzif Z et al (2015) Influence of obesity on vertebral fracture prevalence and vitamin D status in postmenopausal women. Nutr Metab 12(1):44","journal-title":"Nutr Metab"},{"issue":"5","key":"1705_CR59","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1017\/S1368980011000565","volume":"14","author":"AC Ross","year":"2011","unstructured":"Ross AC (2011) The 2011 report on dietary reference intake for calcium and vitamin D. Public Health Nutr Avr 14(5):938\u2013939","journal-title":"Public Health Nutr Avr"},{"issue":"1","key":"1705_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ando.2009.11.009","volume":"71","author":"M Ait Ouazar","year":"2010","unstructured":"Ait Ouazar M, Amine M, Harifi G, Ouilki I, Younsi R, Belkhou A et al (2010) Evaluation of the calcium intake in population of Marrakesh and its region: 1000 cases. Ann Endocrinol 71(1):51\u201355. https:\/\/doi.org\/10.1016\/j.ando.2009.11.009","journal-title":"Ann Endocrinol"},{"key":"1705_CR61","doi-asserted-by":"publisher","unstructured":"Abourazzak FE, Khazzani H, Mansouri S, Ali Ou Alla S, Allali F, El Maghraoui A et al (2016) Recommandations de la Soci\u00e9t\u00e9 Marocaine de Rhumatologie sur la vitamine D chez l\u2019adulte. Rev Mar Rhum 35:3\u201315. https:\/\/doi.org\/10.24398\/a.198.2016","DOI":"10.24398\/a.198.2016"},{"issue":"5","key":"1705_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00198-005-0030-9","volume":"17","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA, Conzelmann M, Stahelin HB, Dick W, Carpenter MG, Adkin AL et al (2006) Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 17(5):656\u2013663","journal-title":"Osteoporos Int"},{"issue":"10","key":"1705_CR63","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7326\/0003-4819-128-10-199805150-00002","volume":"128","author":"MA Schurch","year":"1998","unstructured":"Schurch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP (1998) Protein supplements in-crease serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. Ann Intern Med 128(10):801\u20139","journal-title":"Ann Intern Med"},{"issue":"1","key":"1705_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11914-011-0094-8","volume":"10","author":"SJ Wimalawansa","year":"2012","unstructured":"Wimalawansa SJ (2012) Vitamin D in the new millennium. Curr Osteoporos Rep 10(1):4\u201315","journal-title":"Curr Osteoporos Rep"},{"key":"1705_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jsbmb.2016.09.016","volume":"175","author":"SJ Wimalawansa","year":"2018","unstructured":"Wimalawansa SJ (2018) Non-musculoskeletal benefits of vitamin D. J Steroid Biochem Mol Biol 175:60\u201381","journal-title":"J Steroid Biochem Mol Biol"},{"key":"#cr-split#-1705_CR66.1","unstructured":"Thomas T, Gabach P, Buchon D, Douge M, F\u00e9ron JM, Grange L et al (2015) \u00c9valuation de la prise en charge avant et apr\u00e8s hospitalisation pour fracture de fragilit\u00e9 en France \u00e0 partir des donn\u00e9es de la base SNIIRAM. Congr\u00e8s SFR"},{"key":"#cr-split#-1705_CR66.2","unstructured":"communication O.116 Revue du Rhumatisme 82S (2015) A125. https:\/\/orbi.uliege.be\/bitstream\/2268\/214502\/1\/sfr2015.pdf"},{"issue":"9","key":"1705_CR67","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medica-tion use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29(9):1929\u20131937","journal-title":"J Bone Miner Res"},{"key":"1705_CR68","doi-asserted-by":"crossref","unstructured":"Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA et al (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316(7):722\u201333","DOI":"10.1001\/jama.2016.11136"},{"issue":"4","key":"1705_CR69","first-page":"373","volume":"76","author":"P Szulc","year":"2018","unstructured":"Szulc P, Naylor K, Pickering ME, Hoyle N, Eastell R, Leary E (2018) Use of CTX-I and PINP as bone turno-ver markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Ann Biol Clin (Paris) 76(4):373\u201391","journal-title":"Ann Biol Clin (Paris)"},{"key":"1705_CR70","doi-asserted-by":"crossref","unstructured":"Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY et al (2018) ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis. J Clin Endocrinol Metab 103(8):2949\u201357","DOI":"10.1210\/jc.2018-00163"},{"key":"1705_CR71","doi-asserted-by":"crossref","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for pre-vention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u201365","DOI":"10.1056\/NEJMoa0809493"},{"issue":"11","key":"1705_CR72","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1210\/jc.2013-1597","volume":"98","author":"HG Bone","year":"2013","unstructured":"Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA et al (2013) The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab 98(11):4483\u20134492","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR73","doi-asserted-by":"crossref","unstructured":"Chesnut CH, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res 19(8):1241\u20139","DOI":"10.1359\/JBMR.040325"},{"issue":"1","key":"1705_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1359\/jbmr.0301202","volume":"19","author":"MR McClung","year":"2004","unstructured":"McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH, Ensrud KE et al (2004) Oral daily ibandro-nate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res 19(1):11\u20138","journal-title":"J Bone Miner Res"},{"key":"1705_CR75","doi-asserted-by":"crossref","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: re-sults from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282(7):637\u201345","DOI":"10.1001\/jama.282.7.637"},{"key":"1705_CR76","doi-asserted-by":"crossref","unstructured":"Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344\u201352","DOI":"10.1001\/jama.282.14.1344"},{"key":"1705_CR77","doi-asserted-by":"crossref","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal os-teoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int J Es-tabl Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 11(1):83\u201391","DOI":"10.1007\/s001980050010"},{"issue":"15","key":"1705_CR78","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417\u201327","journal-title":"N Engl J Med"},{"issue":"16","key":"1705_CR79","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u201343","journal-title":"N Engl J Med"},{"issue":"25","key":"1705_CR80","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S et al (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379(25):2407\u201316","journal-title":"N Engl J Med"},{"key":"1705_CR81","first-page":"1535","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Interv Trial Res Group Lancet 348:1535\u20131541","journal-title":"Fracture Interv Trial Res Group Lancet"},{"issue":"18","key":"1705_CR82","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u20131822. https:\/\/doi.org\/10.1056\/NEJMoa067312","journal-title":"N Engl J Med"},{"key":"1705_CR83","doi-asserted-by":"crossref","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett- Connor E, Musliner TA et al (1998) Ef-fect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24):2077\u201382","DOI":"10.1001\/jama.280.24.2077"},{"issue":"11","key":"1705_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.607017","volume":"27","author":"C Zhang","year":"2021","unstructured":"Zhang C, Song C (2021) Combination therapy of PTH and antiresorptive drugs on osteoporosis: a review of treatment alternatives. Front Pharmacol 27(11):607017. https:\/\/doi.org\/10.3389\/fphar.2020.607017","journal-title":"Front Pharmacol"},{"issue":"13","key":"1705_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.888208","volume":"24","author":"Y Sun","year":"2022","unstructured":"Sun Y, Li Y, Li J, Xie X, Gu F, Sui Z, Zhang K, Yu T (2022) Efficacy of the combination of teriparatide and denosumab in the treatment of postmenopausal osteoporosis: a meta-analysis. Front Pharmacol 24(13):888208. https:\/\/doi.org\/10.3389\/fphar.2022.888208","journal-title":"Front Pharmacol"},{"issue":"7","key":"1705_CR86","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jbmr.3471","volume":"33","author":"CJ Crandall","year":"2018","unstructured":"Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA et al (2018) Bone turnover markers are not associated with hip fracture risk: a case-control study in the Women\u2019s Health Initiative. J Bone Miner Res 33(7):1199\u20131208","journal-title":"J Bone Miner Res"},{"key":"1705_CR87","doi-asserted-by":"crossref","unstructured":"Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NFA, McCloskey EV et al (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27(1):21\u201331","DOI":"10.1007\/s00198-015-3145-7"},{"issue":"10","key":"1705_CR88","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00198-008-0661-8","volume":"19","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Watts NB (2008) Assessing response to osteoporosis therapy. Osteoporos Int 19(10):1363\u20138","journal-title":"Osteoporos Int"},{"key":"1705_CR89","doi-asserted-by":"crossref","unstructured":"Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP et al (2004) Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350(12):1189\u201399","DOI":"10.1056\/NEJMoa030897"},{"key":"1705_CR90","doi-asserted-by":"crossref","unstructured":"Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA et al (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term ex-tension (FLEX): a randomized trial. JAMA 296(24):2927\u201338","DOI":"10.1001\/jama.296.24.2927"},{"issue":"12","key":"1705_CR91","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s00198-015-3179-x","volume":"26","author":"S Ferrari","year":"2015","unstructured":"Ferrari S, Adachi JD, Lippuner K, Zapalowski C, Miller PD, Reginster JY et al (2015) Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporos Int 26(12):2763\u20132771","journal-title":"Osteoporos Int"},{"issue":"6","key":"1705_CR92","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","volume":"75","author":"DD Mellstrom","year":"2004","unstructured":"Mellstrom DD, Sorensen OH, Goemaere S, Roux C, Johnson TD, Chines AA (2004) Seven years of treatment with risedronate in women with postmenopausal osteoporosis. Calcif Tissue Int 75(6):462\u20138","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1705_CR93","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/jbmr.2442","volume":"30","author":"DM Black","year":"2015","unstructured":"Black DM, Reid IR, Cauley JA, Cosman F, Leung PC, Lakatos P et al (2015) The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 30(5):934\u2013944","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1705_CR94","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S et al (2012) Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23(1):317\u2013326","journal-title":"Osteoporos Int"},{"issue":"2","key":"1705_CR95","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JEB, McClung M et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo- controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190\u2013198","journal-title":"J Bone Miner Res"},{"key":"1705_CR96","doi-asserted-by":"crossref","unstructured":"Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL et al (2000) Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate 1. J Clin Endocrinol Metab 85(6):2129\u201334","DOI":"10.1210\/jcem.85.6.6614"},{"key":"1705_CR97","doi-asserted-by":"crossref","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF et al (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349(13):1207\u201315","DOI":"10.1056\/NEJMoa031975"},{"key":"1705_CR98","doi-asserted-by":"crossref","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM et al (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet Lond Engl 386(9999):1147\u201355","DOI":"10.1016\/S0140-6736(15)61120-5"},{"issue":"3","key":"1705_CR99","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1210\/jc.2007-0711","volume":"93","author":"S Boonen","year":"2008","unstructured":"Boonen S, Marin F, Obermayer-Pietsch B, Sim\u00f5es ME, Barker C, Glass EV et al (2008) Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab mars 93(3):852\u2013860","journal-title":"J Clin Endocrinol Metab mars"},{"issue":"3","key":"1705_CR100","first-page":"209","volume":"18","author":"H Wang","year":"2015","unstructured":"Wang H, Sribastav SS, Ye F, Yang C, Wang J, Liu H et al (2015) Comparison of percutaneous vertebro-plasty and balloon kyphoplasty for the treatment of single level vertebral compression fractures: a meta-analysis of the literature. Pain Physician 18(3):209\u2013222","journal-title":"Pain Physician"},{"issue":"7","key":"1705_CR101","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.364","volume":"26","author":"S Boonen","year":"2011","unstructured":"Boonen S, Van Meirhaeghe J, Bastian L, Cummings SR, Ranstam J, Tillman JB et al (2011) Balloon ky-phoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res 26(7):1627\u20131637","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1705_CR102","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/jbmr.1564","volume":"27","author":"J Blasco","year":"2012","unstructured":"Blasco J, Martinez-Ferrer A, Macho J, San Roman L, Pom\u00e9s J, Carrasco J et al (2012) Effect of vertebro-plasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12-month randomized follow-up, controlled trial. J Bone Miner Res 27(5):1159\u201366","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1705_CR103","first-page":"715","volume":"24","author":"C Bouza","year":"2015","unstructured":"Bouza C, L\u00f3pez-Cuadrado T, Almendro N, Amate JM (2015) Safety of balloon kyphoplasty in the treat-ment of osteoporotic vertebral compression fractures in Europe: a meta-analysis of randomized controlled trials. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc 24(4):715\u201323","journal-title":"Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc"},{"key":"1705_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105574","volume":"90","author":"J Paccou","year":"2023","unstructured":"Paccou J, Philippoteaux C, Cortet B, Fardellone P (2023) Effectiveness of fracture liaison services in osteoporosis. Joint Bone Spine 90:105574. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105574","journal-title":"Joint Bone Spine"},{"key":"1705_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41584-025-01319-5","volume":"22","author":"M Chandran","year":"2026","unstructured":"Chandran M, Thiyagarajan JA, Alokail M et al (2026) WHO benchmarks for equitable hipfracture care and osteoporosis treatment in older people. Nat Rev Rheumatol 22:62\u201370. https:\/\/doi.org\/10.1038\/s41584-025-01319-5","journal-title":"Nat Rev Rheumatol"},{"key":"1705_CR106","doi-asserted-by":"crossref","unstructured":"Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA et al (2005) Alcohol intake as a risk fac-tor for fracture. Osteoporos Int 16(7):737\u201342","DOI":"10.1007\/s00198-004-1734-y"},{"key":"1705_CR107","doi-asserted-by":"crossref","unstructured":"Giampietro PF, McCarty C, Mukesh B, McKiernan F, Wilson D, Shuldiner A et al (2010) The role of ciga-rette smoking and statins in the development of postmenopausal osteoporosis: a pilot study uti-lizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporos Int 21(3):467\u201377","DOI":"10.1007\/s00198-009-0981-3"},{"issue":"6","key":"1705_CR108","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semarthrit.2008.01.009","volume":"38","author":"F Allali","year":"2009","unstructured":"Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S et al (2009) High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum 38(6):444\u2013451. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.009","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"1705_CR109","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.eprac.2024.10.011","volume":"30","author":"MF Holick","year":"2024","unstructured":"Holick MF (2024) Revisiting vitamin D guidelines: a critical appraisal of the literature. Endocr Pract 30(12):1227. https:\/\/doi.org\/10.1016\/j.eprac.2024.10.011","journal-title":"Endocr Pract"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01705-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01705-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01705-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:02:38Z","timestamp":1777957358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01705-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01705-w","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"77"}}